Fortrea Holdings Inc (FTRE)
19.13
-0.21
(-1.09%)
USD |
NASDAQ |
Nov 18, 13:16
Fortrea Holdings Enterprise Value: 2.754B for Nov. 15, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
November 15, 2024 | 2.754B |
November 14, 2024 | 2.831B |
November 13, 2024 | 2.928B |
November 12, 2024 | 2.988B |
November 11, 2024 | 3.060B |
November 08, 2024 | 3.127B |
November 07, 2024 | 2.638B |
November 06, 2024 | 2.642B |
November 05, 2024 | 2.553B |
November 04, 2024 | 2.532B |
November 01, 2024 | 2.531B |
October 31, 2024 | 2.528B |
October 30, 2024 | 2.558B |
October 29, 2024 | 2.610B |
October 28, 2024 | 2.600B |
October 25, 2024 | 2.574B |
October 24, 2024 | 2.577B |
October 23, 2024 | 2.680B |
October 22, 2024 | 2.616B |
October 21, 2024 | 2.717B |
October 18, 2024 | 2.803B |
October 17, 2024 | 2.759B |
October 16, 2024 | 2.775B |
October 15, 2024 | 2.721B |
October 14, 2024 | 2.672B |
Date | Value |
---|---|
October 11, 2024 | 2.717B |
October 10, 2024 | 2.691B |
October 09, 2024 | 2.737B |
October 08, 2024 | 2.694B |
October 07, 2024 | 2.674B |
October 04, 2024 | 2.705B |
October 03, 2024 | 2.731B |
October 02, 2024 | 2.737B |
October 01, 2024 | 2.781B |
September 30, 2024 | 2.813B |
September 27, 2024 | 2.775B |
September 26, 2024 | 2.772B |
September 25, 2024 | 2.743B |
September 24, 2024 | 2.988B |
September 23, 2024 | 3.014B |
September 20, 2024 | 3.139B |
September 19, 2024 | 3.135B |
September 18, 2024 | 3.057B |
September 17, 2024 | 2.982B |
September 16, 2024 | 2.941B |
September 13, 2024 | 2.914B |
September 12, 2024 | 2.844B |
September 11, 2024 | 2.837B |
September 10, 2024 | 2.782B |
September 09, 2024 | 2.813B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
2.528B
Minimum
Oct 31 2024
5.122B
Maximum
Apr 09 2024
3.939B
Average
4.051B
Median
Enterprise Value Benchmarks
Boston Scientific Corp | 136.84B |
Illumina Inc | 22.47B |
Lumos Pharma Inc | 23.93M |
IQVIA Holdings Inc | 46.77B |
Medpace Holdings Inc | 8.998B |
Enterprise Value Related Metrics
Net Income (Quarterly) | -27.90M |
Revenue (Quarterly) | 674.90M |
Total Expenses (Quarterly) | 684.10M |
EPS Diluted (Quarterly) | -0.31 |
Gross Profit Margin (Quarterly) | 21.97% |
Profit Margin (Quarterly) | -4.13% |
Earnings Yield | -17.77% |
Normalized Earnings Yield | -11.92 |